These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15962098)

  • 1. New insights into the anti-inflammatory actions of aspirin-induction of nitric oxide through the generation of epi-lipoxins.
    Gilroy DW
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():49-54. PubMed ID: 15962098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of aspirin-triggered lipoxins in the mechanism of action of aspirin.
    Gilroy DW
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):203-10. PubMed ID: 15978791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation.
    Paul-Clark MJ; Van Cao T; Moradi-Bidhendi N; Cooper D; Gilroy DW
    J Exp Med; 2004 Jul; 200(1):69-78. PubMed ID: 15238606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New perspectives on aspirin and the endogenous control of acute inflammatory resolution.
    Morris T; Stables M; Gilroy DW
    ScientificWorldJournal; 2006 Aug; 6():1048-65. PubMed ID: 16951898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins.
    Serhan CN; Chiang N
    ScientificWorldJournal; 2002 Jan; 2():169-204. PubMed ID: 12806051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins.
    Fierro IM; Serhan CN
    Braz J Med Biol Res; 2001 May; 34(5):555-66. PubMed ID: 11323741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of low-dose aspirin on acute inflammatory responses in humans.
    Morris T; Stables M; Hobbs A; de Souza P; Colville-Nash P; Warner T; Newson J; Bellingan G; Gilroy DW
    J Immunol; 2009 Aug; 183(3):2089-96. PubMed ID: 19597002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoxins in chronic inflammation.
    Kantarci A; Van Dyke TE
    Crit Rev Oral Biol Med; 2003; 14(1):4-12. PubMed ID: 12764016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring new approaches to the treatment of asthma: potential roles for lipoxins and aspirin-triggered lipid mediators.
    Levy BD; Serhan CN
    Drugs Today (Barc); 2003 May; 39(5):373-84. PubMed ID: 12861350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2, aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance.
    Poorani R; Bhatt AN; Dwarakanath BS; Das UN
    Eur J Pharmacol; 2016 Aug; 785():116-132. PubMed ID: 26335394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipoxins--new view on old mediators carrying potent anti-inflammatory action].
    Jarmakowska K; Kuna P
    Pol Merkur Lekarski; 2005 May; 18(107):491-5. PubMed ID: 16161940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoxins in gastric mucosal health and disease.
    Wallace JL; de Lima OM; Fiorucci S
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):251-5. PubMed ID: 16024242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution.
    Serhan CN
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():433-55. PubMed ID: 12432935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2 in inflammation and resolution.
    Rajakariar R; Yaqoob MM; Gilroy DW
    Mol Interv; 2006 Aug; 6(4):199-207. PubMed ID: 16960142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver: the formation and actions of aspirin-triggered lipoxins.
    Clària J; Planagumà A
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):277-82. PubMed ID: 16006110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide, aspirin-triggered lipoxins and NO-aspirin in gastric protection.
    Wallace JL
    Inflamm Allergy Drug Targets; 2006 Apr; 5(2):133-7. PubMed ID: 16613572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation.
    Gewirtz AT; Fokin VV; Petasis NA; Serhan CN; Madara JL
    Am J Physiol; 1999 Apr; 276(4):C988-94. PubMed ID: 10199831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side.
    Serhan CN
    Arch Immunol Ther Exp (Warsz); 2001; 49(3):177-88. PubMed ID: 11478391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.